TrialCirculation2017

Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin).

Neha J Pagidipati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.